Detalhe da pesquisa
1.
Randomized Phase I Trial of the α-Synuclein Antibody Lu AF82422.
Mov Disord
; 2024 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494847
2.
A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease.
Mov Disord
; 37(5): 1088-1093, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218231
3.
Diagnostic criteria for apathy in neurocognitive disorders.
Alzheimers Dement
; 17(12): 1892-1904, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33949763
4.
Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials.
Am J Geriatr Psychiatry
; 28(4): 383-400, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31708380
5.
Open-label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver Stiffness and/or Hepatic Steatosis.
Alcohol Alcohol
; 55(1): 63-70, 2020 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31713583
6.
Long-term safety and efficacy of nalmefene in Japanese patients with alcohol dependence.
Psychiatry Clin Neurosci
; 74(8): 431-438, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32359104
7.
Nalmefene in alcohol-dependent patients with a high drinking risk: Randomized controlled trial.
Psychiatry Clin Neurosci
; 73(11): 697-706, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31298784
8.
Nalmefene, Given as Needed, in the Routine Treatment of Patients with Alcohol Dependence: An Interventional, Open-Label Study in Primary Care.
Eur Addict Res
; 24(6): 293-303, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30485854
9.
Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies.
Hum Psychopharmacol
; 25(2): 103-15, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20196185
10.
Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
JAMA Psychiatry
; 76(4): 374-381, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865232
11.
Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia.
Int Clin Psychopharmacol
; 23(2): 95-105, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18301124
12.
Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study.
Biol Psychiatry
; 81(11): 941-948, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28216062
13.
The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders.
Neuropsychopharmacology
; 37(2): 402-11, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900883
14.
A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
Psychopharmacol Bull
; 43(4): 37-69, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21240151
15.
A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.
J Clin Psychiatry
; 70(4): 487-99, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19358783
16.
The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study.
Psychopharmacol Bull
; 41(3): 11-35, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18779774
17.
Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients.
Psychiatry (Edgmont)
; 4(11): 34-50, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20428302
18.
Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.
J Clin Psychiatry
; 68(6): 832-42, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17592906